01 28ARIPIPRAZOLE
02 13Aripiprazol
03 28Aripiprazole
04 7Aripiprazolum
05 12BREXPIPRAZOLE
06 1CEDAZURIDINE
07 1CEDAZURIDINE; DECITABINE
08 2CILOSTAZOL
09 2DECITABINE
10 1DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
11 1Decitabine, Cedazuridine
12 1FERRIC AMMONIUM CITRATE
13 1FUTIBATINIB
14 3GREPAFLOXACIN HYDROCHLORIDE
15 1IOHEXOL
16 2TIPIRACIL (TIPIRACIL HYDROCHLORIDE)
17 2TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
18 20TOLVAPTAN
19 2TRIFLURIDINE
20 14Tolvaptan
21 5Tolvaptanum
22 2UREA C-13
23 1Voclosporin
24 4aripiprazole
25 9aripiprazole (anhydrous)
26 4aripiprazolmonohydrat
27 2cilostazol
28 4decitabine + cedazuridine
29 17tolvaptan
30 3Blank
01 1AVANIR PHARMS
02 1INTERPHARMA PRAHA AS
03 42OTSUKA
04 2OTSUKA AMERICA
05 10OTSUKA PHARMAC.EUROPE LTD
06 26OTSUKA PHARMACEUTICAL CO LTD
07 9OTSUKA PHARMACEUTICAL NETHERLANDS BV
08 18Otsuka Australia Pharmaceutical Pty. Ltd
09 13Otsuka Pharmaceutical (Switzerland) GmbH
10 4Otsuka Pharmaceutical Europe
11 14Otsuka Pharmaceutical Europe Ltd
12 2Otsuka Pharmaceutical Europe Ltd (2)
13 18Otsuka Pharmaceutical Europe Ltd,
14 3Otsuka Pharmaceutical Europe Ltd.
15 21Otsuka Pharmaceutical Netherlands B.V.
16 3TAIHO ONCOLOGY
17 6TAIHO PHARMA CANADA, INC.
01 10Antic-calc Tablet
02 2Aripiprazole 10Mg 28 Combined Oral Use
03 2Aripiprazole 15Mg 28 Combined Oral Use
04 1Aripiprazole 1Mg/Ml 150Ml Oral Use
05 1Aripiprazole 400Mg 2 Ml 1 Units Parenteral Use Rp
06 1Aripiprazole 5Mg 28 Combined Oral Use
07 1Aripiprazole 9,75Mg 1,3Ml 1 Unit Parenteral Use
08 1CAPSULE;ORAL
09 1Depot solution for injection, suspension in pre-filled syringe
10 4FOR SOLUTION;ORAL
11 1INJECTABLE;INTRAMUSCULAR
12 1INJECTABLE;INTRAVENOUS
13 1Injection fluid, resolution
14 2Melting tablet
15 1Mixture, solution
16 1ORAL SOLUTION
17 3ORODISPERSIBLE TABLET
18 1Oral Solution Oral Use Pet
19 2Orodispersible Tablet
20 4POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
21 2POWDER FOR SUSPENSION, SUSTAINED-RELEASE
22 1Potion, resolution
23 1Powder and liquid for depot injection, suspension
24 1Powder and liquid for depot injection, suspension in pre-filled syringe
25 2Powder and liquid to depot injection fluid, suspension
26 1SOLUTION FOR INJECTION
27 1SOLUTION;ORAL
28 2SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
29 2Schmelztabl
30 1Sirup
31 2Smeltetablett
32 1Soft Capsules
33 1Solution for injection
34 43TABLET
35 4TABLET, ORALLY DISINTEGRATING;ORAL
36 35TABLET;ORAL
37 7Tabl
38 18Tablet
39 1Tablet, film-coated
40 4Tablet; Tablet
41 1Tolvaptan 15Mg 10 Units Oral Use
42 1Tolvaptan 30Mg 10 Units Oral Use
43 4tablet
44 16Blank
01 20.25MG
02 20.5MG
03 11 MG / ML
04 21 mg/ml
05 11 vial IM 1,3 ml 7,5 mg/ml
06 11 vial IM 400 mg + 1 vial solv 2 ml sustained release
07 110 CPR 15 mg
08 110 CPR 30 mg
09 210 MG
10 710 mg
11 1100 MG
12 1100MG
13 1100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
14 1100MG;35MG
15 310MG
16 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
17 310mg
18 1125MG/VIAL
19 1015 mg
20 115 mg + 45 mg
21 1515MG
22 115MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 415mg
24 21MG
25 11MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
26 21mg/ml
27 120 mg
28 420MG
29 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
30 120MG;10MG
31 128 CPR 10 mg
32 128 CPR 15 mg
33 128 CPR 5 mg
34 128 cpr orodispers 10 mg
35 128 cpr orodispers 15 mg
36 52MG
37 430 MG
38 530 mg
39 130 mg + 60 mg
40 130 mg + 90 mg
41 2300 MG
42 1300MG/VIAL
43 930MG
44 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
45 230mg
46 135MG
47 135mg/100mg
48 437ML; 100MG
49 23MG
50 2400 MG
51 4400 mg
52 1400MG/VIAL
53 145 MG + 15 MG
54 245MG
55 145mg/15mg
56 34MG
57 15 MG
58 55 mg
59 150 MG
60 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
61 150MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
62 35MG
63 25mg
64 16.14MG
65 160 MG + 30 MG
66 1600MG/PACKET
67 260MG
68 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
69 160mg/30mg
70 17.5 MG / ML
71 27.5 mg
72 27.5 mg/ml
73 17.9mg
74 1720MG/2.4ML (300MG/ML)
75 18.19MG
76 19.75MG/1.3ML (7.5MG/ML)
77 19.7GM/BOT
78 190 MG + 30 MG
79 290MG
80 190mg/30mg
81 1960 mg
82 1960MG/3.2ML (300MG/ML)
83
3
84 1EQ 200MG BASE
85 1EQ 400MG BASE
86 1EQ 6.14MG BASE;15MG
87 1EQ 600MG BASE
88 1EQ 75MG/POUCH
89 1EQ 8.19MG BASE;20MG
90 1os soluz 1 Bottle 150 ml 1 mg/ml
91 13Blank
01 18Australia
02 32Canada
03 19Italy
04 40Norway
05 22Sweden
06 13Switzerland
07 49USA
Regulatory Info :
Registration Country : Norway
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 15 mg
Packaging : Endose blister pack 28 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 10 mg
Packaging : Endose blister pack 56 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 30 mg
Packaging : Endose blister pack 56 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 5 mg
Packaging : Endose blister pack 28 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 5 mg
Packaging : Endose blister pack 56 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Melting tablet
Brand Name : Abilify
Dosage Strength : 10 mg
Packaging : Blisterpakning 28item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Depot solution for injec...
Brand Name : Abilify Maintena
Dosage Strength : 960 mg
Packaging : Pre-filled syringe 3.2ml, pcs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Solution for injection
Brand Name : Abilify
Dosage Strength : 7.5 mg/ml
Packaging : Vials 1 1.3ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Powder and liquid for de...
Brand Name : Abilify Maintena
Dosage Strength : 400 mg
Packaging : Vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Powder and liquid for de...
Brand Name : Abilify Maintena
Dosage Strength : 400 mg
Packaging : Pre-filled glass syringe 2ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Otsuka Holdings is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Difamilast bulk with DMF offered by Otsuka Holdings
Find a price of Oranekishijin hydrochloride hydrate bulk with JDMF offered by Otsuka Holdings
LOOKING FOR A SUPPLIER?
